Aleksandra Wieczorek

9PUBLICATIONS
40CO-AUTHORS
Infant and child healthCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyHaematological tumoursRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 28, 2026
Multicenter analysis of [123I/131I]I-mIBG imaging in pediatric neuroblastoma - effective dose estimation.

|Sep 26, 2026
Incidence of Veno-Occlusive Disease in Patients with Neuroblastoma Treated with Autologous Stem Cell Transplantation After Chemoimmunotherapy with Temozolomide, Irinotecan, and Dinutuximab Beta.

|Sep 13, 2025
Dinutuximab Beta Versus Naxitamab in the Treatment of Relapsed/Refractory Neuroblastoma in Patients with Stable Disease, Minor Response or Partial Response and Disease in Bone or Bone Marrow: Systematic Review and Matching-Adjusted Indirect Comparison.

Holger N Lode, Przemysław Holko, Aleksandra Wieczorek

|Jun 03, 2025
Efficacy and Safety of Anti-GD2 Immunotherapy with Dinutuximab Beta in the Treatment of Relapsed/Refractory High-Risk Neuroblastoma.

Aleksandra Wieczorek, Katarzyna Śladowska, Holger N Lode

|Mar 13, 2024
Anti-PD-1 Therapy in Advanced Pediatric Malignancies in Nationwide Study: Good Outcome in Skin Melanoma and Hodgkin Lymphoma.

Agata Marjańska, Katarzyna Pawińska-Wąsikowska, Aleksandra Wieczorek

|Feb 24, 2024
Survival Benefit of Myeloablative Therapy with Autologous Stem Cell Transplantation in High-Risk Neuroblastoma: A Systematic Literature Review.

Urszula Żebrowska, Walentyna Balwierz, Jarosław Wechowski

Pageof 2

Frequent Collaborators

4 joint publications

Holger N Lode

3 joint publications

Walentyna Balwierz

2 joint publications

Jan Styczyński

2 joint publications

Krzysztof Kałwak